David A. Siegel Novo Nordisk A S Transaction History
Two Sigma Advisers, LP
- $46.1 Billion
- Q2 2025
A detailed history of David A. Siegel (Two Sigma Advisers, LP) transactions in Novo Nordisk A S stock. As of the latest transaction made, Two Sigma Advisers, LP holds 1,391,700 shares of NVO stock, worth $76.2 Million. This represents 0.21% of its overall portfolio holdings.
Number of Shares
1,391,700
Previous 4,856,800
71.35%
Holding current value
$76.2 Million
Previous $337 Million
71.52%
% of portfolio
0.21%
Previous 0.79%
Shares
31 transactions
Others Institutions Holding NVO
# of Institutions
1,724Shares Held
313MCall Options Held
13.7MPut Options Held
19.7M-
Jennison Associates LLC18.9MShares$1.03 Billion0.78% of portfolio
-
Bank Of America Corp Charlotte, NC14.7MShares$806 Million0.08% of portfolio
-
Morgan Stanley New York, NY14.3MShares$783 Million0.07% of portfolio
-
Loomis Sayles & CO L P12.6MShares$689 Million1.12% of portfolio
-
Capital International Investors Los Angeles, CA11.6MShares$637 Million0.14% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $124B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...